TODMORDEN GROUP PRACTICE — All Prescriptions & Medications — Page 13
Practice Code: B84006 | TODMORDEN, OL14 5RN
Showing results 601-650 of 702
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Levofloxacin | 15 | 635 | £389 | +253.4% ▲ |
| 15 | 555 | £50 | -49.8% ▼ | |
| 15 | 275 | £359 | +37.0% ▲ | |
| 15 | 231 | £628 | -4.4% ▼ | |
| 15 | 250 | £209 | -59.6% ▼ | |
| 15 | 450 | £849 | +1.0% vs avg | |
| 15 | 4,155 | £728 | -61.8% ▼ | |
| 15 | 870 | £2.7K | +17.4% ▲ | |
| 15 | 2,250 | £734 | +178.1% ▲ | |
| 15 | 600 | £1.2K | +37.1% ▲ | |
| Olsalazine sodium | 14 | 392 | £1.1K | +39.5% ▲ |
| Lithium citrate | 14 | 8,400 | £620 | +55.7% ▲ |
| Alendronic acid/colecalciferol | 14 | 56 | £303 | +82.5% ▲ |
| Norethisterone | 14 | 1,372 | £34 | +0.1% vs avg |
| Calcium acetate | 14 | 2,100 | £151 | -24.3% ▼ |
| Tube feed 1.5 kcal/ml (0914021) | 14 | 359.0K | £8.2K | +65.5% ▲ |
| Tube feed 1.5 kcal/ml with fibre (0914021) | 14 | 181.5K | £4.5K | +22.2% ▲ |
| Tube feed 1 kcal/ml peptide based (0914032) | 14 | 380.0K | £9.0K | +56.9% ▲ |
| Diethylamine salicylate | 14 | 700 | £22 | -48.1% ▼ |
| Other treatment of dry mouth preparations | 14 | 1,400 | £31 | +113.1% ▲ |
| Zinc oxide | 14 | 5,600 | £146 | -30.4% ▼ |
| Benzoyl peroxide | 14 | 830 | £124 | -0.7% vs avg |
| Salicylic acid | 14 | 144 | £49 | +10.7% ▲ |
| Other toiletry preparations | 14 | 4,250 | £66 | -67.2% ▼ |
| 14 | 28 | £86 | -65.6% ▼ | |
| 14 | 38 | £666 | +209.0% ▲ | |
| 14 | 500 | £658 | +52.1% ▲ | |
| Linaclotide | 13 | 364 | £464 | -28.8% ▼ |
| Valsartan/amlodipine | 13 | 364 | £328 | +18.5% ▲ |
| Sulpiride | 13 | 930 | £579 | -51.5% ▼ |
| Doxylamine succinate/pyridoxine hydrochloride | 13 | 722 | £1.0K | +17.8% ▲ |
| Oxycodone hydrochloride/naloxone hydrochloride | 13 | 728 | £1.1K | -25.0% ▼ |
| Apomorphine hydrochloride | 13 | 590 | £9.8K | +17.2% ▲ |
| Erythromycin ethylsuccinate | 13 | 2,300 | £189 | -44.3% ▼ |
| Liothyronine sodium | 13 | 728 | £1.4K | -39.1% ▼ |
| Tamsulosin and dutasteride hydrochloride | 13 | 364 | £100 | -62.8% ▼ |
| Alprostadil | 13 | 60 | £584 | -24.0% ▼ |
| Hydroxycarbamide | 13 | 468 | £74 | -54.9% ▼ |
| 13 | 86.2K | £1.4K | +43.4% ▲ | |
| Ketoprofen | 13 | 2,600 | £112 | -63.8% ▼ |
| Loteprednol etabonate | 13 | 65 | £68 | +40.6% ▲ |
| Betaxolol | 13 | 65 | £24 | +36.7% ▲ |
| Ciprofloxain/dexameth | 13 | 75 | £87 | -57.7% ▼ |
| Fludroxycortide | 13 | 13 | £289 | +23.3% ▲ |
| Clindamycin/tretinoin | 13 | 450 | £170 | +10.8% ▲ |
| Heparinoid | 13 | 650 | £49 | -0.3% vs avg |
| 13 | 750 | £158 | +93.1% ▲ | |
| 13 | 1,040 | £530 | +129.1% ▲ | |
| 13 | 330 | £1.6K | -7.1% ▼ | |
| Mebeverine hydrochloride compound preparations | 12 | 536 | £467 | +6.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.